MedPath

Diagnostic Performance of PET/CT and Bone Scintigraphy in Breast Cance Patients with Suspected Bone Metastasis

Not Applicable
Conditions
Breast cancer
Registration Number
JPRN-UMIN000006003
Lead Sponsor
Tokai University school of medicine Department of Breast Endocrine Surgery
Brief Summary

Our results indicated that PET/CT was superior to BS for the diagnosis of bone metastases. On the basis of the results of previous studies as well as ours, PET/CT could replace BS as the initial modality to detect bone metastases in patients suspected for the condition.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Prior diagnosed bone metastases from breast cancer ECOG PS0-1 Pre-existing pulmonary and/or cardiac disease Pre-existing ascites and pleural effusion. Pre-existing infection disease Patient have drug allergy Pre-existing mental disorder Prior autologous bone marrow transplantation Pre-existing brain metastasis History of any other cancer (except no-invasive cancer) Pregnant or sexually active women not using reliable contraception

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sensitivity and specificity
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath